title: Concurrent use of statins does not influence efficacy of maraviroc in Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients 1 and 2 trials.
authors.forename: Graeme
authors.initials: G
authors.lastname: Moyle
authors.forename: Natasa
authors.initials: N
authors.lastname: Rajicic
authors.forename: James
authors.initials: J
authors.lastname: Goodrich
authors.forename: Howard
authors.initials: H
authors.lastname: Mayer
authors.forename: Hernan
authors.initials: H
authors.lastname: Valdez
mesh_terms: D065100:CCR5 Receptor Antagonists; D003510:Cyclohexanes / Q000627:therapeutic use*; D004347:Drug Interactions; D023581:HIV Fusion Inhibitors / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000302:isolation & purification*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D000077592:Maraviroc; D016896:Treatment Outcome; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D065100:CCR5 Receptor Antagonists; D003510:Cyclohexanes; D023581:HIV Fusion Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014230:Triazoles; D000077592:Maraviroc